How do you pay?

How to pay the least

Ask for the cash price

Gvoke HypoPen

No generic is sold yet.

  1. Ask your pharmacy for Gvoke HypoPen’s cash price, and one or two other pharmacies too.
  2. Gvoke HypoPen’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameGvoke HypoPen
Authorized genericglucagon
Regular genericglucagon
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Gvoke HypoPen?
The original
–
–

Brand nameThe maker’s card

Gvoke Copay Card

Savings card from Xeris Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 a fill

Print the card from gvokeglucagon.com 

See the offer on gvokeglucagon.com

In the maker’s words

“Eligible commercially insured patients may pay as little as $25 for Gvoke HypoPen.”

From the maker’s offer on gvokeglucagon.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Gvoke HypoPen itself, from the same company, sold without the brand name, and usually for less. For now Gvoke HypoPen is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says
  • GVOKE is an antihypoglycemic agent indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged two years and older with diabetes
  • GVOKE VialDx is a gastrointestinal motility inhibitor indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients

Source: the FDA label for Gvoke HypoPen (Xeris Pharmaceuticals, Inc.), October 6, 2026. Full label on DailyMed 

Good to know